VEGFA and breast cancer: In the present study, we analysed the role of ACE2 in breast cancer prognosis using databases and human tissues, verified the anti-angiogenetic effects of ACE2 in vitro and in vivo and then revealed the VEGFa/VEGFR2/ERK pathway.